Literature DB >> 29256180

IL-2 mediates NK cell proliferation but not hyperactivity.

Richa Sharma1, Asmita Das2.   

Abstract

Natural killer cells play a major role in innate immunity against tumor and virus-infected cells. NK cells express activating and inhibitory receptors to regulate their function. It has been established that modulation in the NK cell receptor profile results in altered function of NK cell against target cells. Here, we study the effect of IL-2 stimulation on NK cell inhibitory receptors Ly49A, Ly49C, and activating receptor Ly49D in C57BL/6 mice. It was observed that there was significant increase in expression of Ly49A but no change in expression of Ly49C and Ly49D on IL-2 stimulation. We further noticed that although IL-2 stimulation increased the NK cell population and expression of activation marker NK1.1 but IL-2 stimulation does not cause hyper-responsiveness in NK cells, as there was no increase in MIP-1α and IFN-γ production in IL-2 stimulated NK cells as compared to unstimulated controls. These findings provide a framework to understand the effect of IL-2 stimulation on cognate and non-cognate receptor ligand interactions and suggest stratagies for immunotherapies in conjunction with IL-2 combinatorial therapies.

Entities:  

Keywords:  IL-2; Ly49A; Ly49C; Ly49D; NK cell receptors; NK cells; NK1.1

Mesh:

Substances:

Year:  2018        PMID: 29256180     DOI: 10.1007/s12026-017-8982-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  29 in total

1.  Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.

Authors:  Steven A Rosenberg; James C Yang; Richard M Sherry; Udai S Kammula; Marybeth S Hughes; Giao Q Phan; Deborah E Citrin; Nicholas P Restifo; Paul F Robbins; John R Wunderlich; Kathleen E Morton; Carolyn M Laurencot; Seth M Steinberg; Donald E White; Mark E Dudley
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

2.  Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.

Authors:  T Hanke; D H Raulet
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 3.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  Decreased percentage of NKG2D+NK cells in patients with incident onset of Type 1 Diabetes.

Authors:  Yupan Zhang; Haifeng Wang; Xiaoqian Lou; Xiaozhang Qu; Lichao Gao; Xiaolei Liu; Man Li; Hui Guo; Yanfang Jiang
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-02       Impact factor: 2.557

5.  Natural killer cell proliferation induced by anti-NK1.1 and IL-2.

Authors:  A Reichlin; W M Yokoyama
Journal:  Immunol Cell Biol       Date:  1998-04       Impact factor: 5.126

6.  Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.

Authors:  Julia S Schleypen; Nicole Baur; Robert Kammerer; Peter J Nelson; Karl Rohrmann; Elisabeth F Gröne; Markus Hohenfellner; Axel Haferkamp; Heike Pohla; Dolores J Schendel; Christine S Falk; Elfriede Noessner
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

7.  Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.

Authors:  Siri Tähtinen; Saija Kaikkonen; Maiju Merisalo-Soikkeli; Susanna Grönberg-Vähä-Koskela; Anna Kanerva; Suvi Parviainen; Markus Vähä-Koskela; Akseli Hemminki
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.

Authors:  Joanna S Kritikou; Carin I M Dahlberg; Marisa A P Baptista; Arnika K Wagner; Pinaki P Banerjee; Lavesh Amar Gwalani; Cecilia Poli; Sudeepta K Panda; Klas Kärre; Susan M Kaech; Fredrik Wermeling; John Andersson; Jordan S Orange; Hanna Brauner; Lisa S Westerberg
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

9.  Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells.

Authors:  Subhashis Sarkar; Wilfred T V Germeraad; Kasper M A Rouschop; Elisabeth M P Steeghs; Michel van Gelder; Gerard M J Bos; Lotte Wieten
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis.

Authors:  Haruo Ohtani; Kazuko Mori-Shiraishi; Morio Nakajima; Hamaichi Ueki
Journal:  Pathol Int       Date:  2015-11-04       Impact factor: 2.534

View more
  12 in total

1.  [Construction and evaluation of dual-effect cord blood natural killer cells expressing highaffinity PD-1 and chimeric antigen CD19 receptor].

Authors:  H Zhong; Q Zou; H Liu; X Wang; S DU; H Liang; Z Wu; J Ye; Q Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

2.  Notch1 is crucial for decidualization and maintaining the first pregnancy in the mouse†.

Authors:  Yao Wu; Jia-Peng He; Juan Xie; Ke-Zhi Wang; Jin-Wen Kang; Asgerally T Fazleabas; Ren-Wei Su
Journal:  Biol Reprod       Date:  2021-03-11       Impact factor: 4.285

3.  Propofol Promotes Activity and Tumor-Killing Ability of Natural Killer Cells in Peripheral Blood of Patients with Colon Cancer.

Authors:  Dongshui Liu; Xiaoshan Sun; Yue Du; Minmin Kong
Journal:  Med Sci Monit       Date:  2018-09-03

4.  Schistosoma japonicum Infection Promotes the Response of Tfh Cells Through Down-Regulation of Caspase-3-Mediating Apoptosis.

Authors:  Quan Yang; Jiale Qu; Chenxi Jin; Yuanfa Feng; Shihao Xie; Jinxin Zhu; Gaoshen Liu; Hongyan Xie; Huaina Qiu; Yanwei Qi; Jianbing Mu; Jun Huang
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

Review 5.  Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress.

Authors:  Yixi Zhang; Pan Li; Hongyu Fang; Guocan Wang; Xun Zeng
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

Review 6.  Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity.

Authors:  Anwen Ren; Wei Yin; Heather Miller; Lisa S Westerberg; Fabio Candotti; Chan-Sik Park; Pamela Lee; Quan Gong; Yan Chen; Chaohong Liu
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

7.  IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25+Foxp3- T cells.

Authors:  Jakub Tomala; Petra Weberova; Barbora Tomalova; Zuzana Jiraskova Zakostelska; Ladislav Sivak; Jirina Kovarova; Marek Kovar
Journal:  Elife       Date:  2021-12-21       Impact factor: 8.140

8.  Mathematical Modeling of Proliferative Immune Response Initiated by Interactions Between Classical Antigen-Presenting Cells Under Joint Antagonistic IL-2 and IL-4 Signaling.

Authors:  Komlan Atitey; Benedict Anchang
Journal:  Front Mol Biosci       Date:  2022-01-28

9.  Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells.

Authors:  Evelyn O Ojo; Ashish Arunkumar Sharma; Ruifu Liu; Stephen Moreton; Mary-Ann Checkley-Luttge; Kalpana Gupta; Grace Lee; Dean A Lee; Folashade Otegbeye; Rafick-Pierre Sekaly; Marcos de Lima; David N Wald
Journal:  Sci Rep       Date:  2019-10-17       Impact factor: 4.379

10.  Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells.

Authors:  L Herrera; S Santos; M A Vesga; J Anguita; I Martin-Ruiz; T Carrascosa; M Juan; C Eguizabal
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.